Story perspectives

FDA Warns Chest-Binder Companies Amid Transgender Care Debate

12/23/2025

Summary

Story summary

The U.S. Food and Drug Administration (FDA) issued warning letters to 12 chest-binder companies for not registering binders as medical devices.
The action coincides with proposed Department of Health and Human Services rules restricting gender-affirming care for minors.
Critics including Brandon Wolf of the Human Rights Campaign say the move targets transgender lives.
Companies have 15 days to respond and contend binders are not medical devices but compression garments.

1 of 1

Story summary

The U.S. Food and Drug Administration (FDA) issued warning letters to 12 chest-binder companies for not registering binders as medical devices.
The action coincides with proposed Department of Health and Human Services rules restricting gender-affirming care for minors.
Critics including Brandon Wolf of the Human Rights Campaign say the move targets transgender lives.
Companies have 15 days to respond and contend binders are not medical devices but compression garments.